World Updates
Keep an eye on global cues, currency movements, and sectoral performance as the stock market opens with advances on the GIFT Nifty! With gains of around 0.18% in the early hours, GIFT Nifty showed a strong opening for Indian shares on Friday, trading around the 25,400 level. Market Opening Outlook for Indian Equities Following recent … Read more
According to the securities laws of some jurisdictions, such as the United States Private Securities Litigation Reform Act of 1995, this release may contain “forward-looking statements.” Forward-Looking Statements Overview Every statement that is not based on historical facts is either forward-looking or might be considered such. Words and phrases like “will,” “aim,” “expects,” “anticipates,” “intends,” … Read more
Following pressure on its October-December quarter profitability due to a mix of new labor rules, regulatory action, and major operational disruptions in December, IndiGo dramatically reduced its forecasts for near-term growth. IndiGo Reports Worst Q3 Profit in Four Years For the third quarter of fiscal year 2026 (FY26), India’s largest carrier reported a 78% year-over-year … Read more
The traditional budgeting method known as the 50/30/20 rule may be familiar to you. It states that you should set aside 20% of your income for savings, 30% for wants, and 50% for necessities. Grant Cardone’s 40/40/20 Rule for Wealth Creation However, Grant Cardone, the author of the upcoming book “The Wealth Creation Formula,” offers … Read more
After getting approval from the Delhi High Court last week, Zydus Lifesciences introduced its biosimilar of the anti-cancer medication nivolumab in India, priced it significantly less than the patented version. Zydus Launches Nivolumab Biosimilar in India The medication, which was introduced under the brand name Tishtha, costs ₹13,950 for a 40-mg dose and ₹28,950 for … Read more